Advances and challenges in functionalised surface modification of liposomes for cytoplasmic drug delivery
Zimei Wu
The University of Auckland, New Zealand
: Androl Gynecol: Curr Res
Abstract
Chemotherapy continues to play an important role in cancer treatment, but still faces major challenges, mainly poor tumour-selectivity and drug resistance. ‘Targeted drug delivery’ with liposomes has attracted great attention due to their potential for improving chemotherapeutic index and 15 liposomal products are already approved for clinical use. Surface modification of liposomes with poly(ethylene glycol) (PEG) is still the gold standard. However, growing evidence shows that although the side effects in patients have been minimized by the use of PEGylated liposomes, the improvement in efficacy is usually marginal. This could partially be attributed to the poor cellular uptake and slow intracellular drug release as a result of PEGylation, known as PEG dilemma. This talk will outline the recent advances and principles for ‘tumourtargeted cytoplasmic drug delivery’ using new liposomes modified with various functionalized polymers in alternative to PEG. The strategy of tumour microenvironment-sensitive PEGdetachment will also be discussed. A greater understanding of these mechanisms will help to design more efficient drug delivery systems to address the challenges encountered in the current liposomal chemotherapy
Biography
Zimei Wu is an Associate Professor (British) at School of Pharamcy, University of Auckland, New Zeland. She holds a PhD from University of Otago and a Masters degree from China Pharamceutical University. In 2009, Dr Wu was appointed as a lecturer at Auckland School of Pharmacy, where she established research platform on ‘tumour targeted delivery’. Her research on ‘liposomes’ has attracted wide collaborations natioanlly and internationally, and was a recipient of NZ-China Scientist Exchange Award from the Royal Society of NZ. She also researches transdermal delivery with successful stories featured on NZTV3 (2015). Zimei has over 90 peer-reviewed articles and book/chapters that have been cited over 1000 times (h-index 20). She serves as an editorial board member of Journal of Liposome Research, and Pharmaceutical Development and Technology, and a referee for more than 20 pharmaceutical journals. Zimei is the immidieate Past President of NZ Local Chapter of Controlled Release Society
E-mail: e: z.wu@auckland.ac.nz
